Delivery Order SPE2DB24D2205-SPE2DB25FEFPZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $1,463.34 on June 25, 2025. This is a firm fixed price delivery order with an ultimate completion date of June 26, 2025. The award was made through open competition without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,761.94 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on June 16, 2025, with an ultimate completion date of June 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,171.80 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10mL) with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,296.60 for NovoLog 100 Unit/mL vials (10 mL) on August 12, 2025, with completion targeted for August 13, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) with a ceiling value of $1,119.06. The contract, awarded September 2, 2025, with completion by September 3, 2025, utilizes firm fixed price pricing and represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) with a ceiling value of $2,124.91. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency has awarded a delivery order valued at $14,289.56 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract awarded on a competitive basis. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a $1,296.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside contract represents a single delivery order fulfilling federal pharmaceutical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,664.69 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL). The award is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,204.22 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) under a firm fixed price contract. This is a non-set-aside award issued on August 25, 2025, with an ultimate completion date of August 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFPZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $8,721.50 under a Firm Fixed Price contract type. The delivery order, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This pharmaceutical supply delivery supports DLA's medical supply chain operations and aligns with the company's established role as a critical vendor for federal healthcare procurement. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's contract portfolio demonstrates its extensive capability to deliver specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 7/30/25 |